<unk>  is indicated as adjunctive therapy to diet and exercise in high cardiovascular risk adults with mixed dyslipidemia to reduce triglycerides and increase HDL C levels when LDL C levels are adequately controlled with the corresponding dose of<unk>  monotherapy.
Fenofibrate/simvastatin
Ezetimibe/atorvastatin
Ezetimibe/simvastatin
Fenofibrate/pravastatin
Ezetimibe/rosuvastatin
Bempedoic acid/ezetimibe
Amlodipine/atorvastatin
Sitagliptin/metformin